Antiviral drugs are pharmaceuticals that inhibit the replication of viruses by targeting specific virus-encoded enzymes or proteins essential for their replication. These drugs are used to treat viral infections like HIV, herpes, hepatitis, influenza and others. Different classes of antiviral drugs are available including nucleoside analogues, protease inhibitors, reverse transcriptase inhibitors and others. Some commonly used antiviral drugs include oseltamivir, acyclovir, lamivudine, tenofovir and lopinavir/ritonavir. These drugs are available in various dosage forms like oral tablets, capsules, suspensions and injections depending on route of administration and patient preference.

The global antiviral drugs market is estimated to be valued at US$ 70,646.07 Bn or Mn in 2023 and is expected to exhibit a CAGR of 23% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
Rising incidence of infectious diseases due to growing threat of epidemics and pandemics is a key driver augmenting the antiviral drugs market growth. As per WHO, viral infectious diseases like HIV, hepatitis, influenza etc. impose a huge burden on public health worldwide. Growing prevalence of these diseases has led to increased consumption of antiviral drugs for treatment purposes. Furthermore, high occurrence of seasonal influenza and emergence of new viruses also fuel the demand for antiviral medications to control disease outbreaks. Additionally, development of novel antiviral drug formulations and pipelines is expected to offer lucrative opportunities over the forecast period. However, lengthy drug approval process and high costs associated with R&D may hamper market growth.

SWOT Analysis
Strength: Antiviral drugs help boost immunity and fight against infections caused by viruses like influenza, hepatitis, HIV, herpes etc. New drug formulations with enhanced potency and fewer side effects are boosting the demand. Growing prevalence of viral infections due to changing lifestyle and environment is supporting market growth.

Weakness: Developing new antiviral drugs is a lengthy and expensive process. The effectiveness of antiviral drugs is limited since viruses tend to mutate rapidly. This reduces drug efficacy over time. Side effects of some antiviral medications affect patient compliance.

Opportunity: Rising geriatric population susceptible to viral infections presents an opportunity. Untapped markets in developing countries offer scope for market expansion. Increasing R&D investments for developing novel antiviral therapies against emerging and re-emerging viruses are encouraging.

Threats: Patent expiries of blockbuster antiviral drugs impact market revenues. Stringent regulatory norms for approval delay market entry of new drugs. Substandard duplicate products erode brand loyalty and affect sales.

Key Takeaways
The global Antiviral Drugs Market Share is expected to witness high growth.

North America is currently the largest as well as the fastest growing regional market owing to rising prevalence of viral infections, strong healthcare infrastructure and high adoption of new therapies. The revenue from the United States alone accounts for over 40% of the global market share.
Asia Pacific region is poised to witness remarkable growth over the forecast period supported by improving healthcare infrastructure, economic development, changing lifestyles and increasing awareness about treatment options in major countries like China and India. Between 2024-2031, the Asia Pacific antiviral drugs market is anticipated to register a CAGR of over 25%.

Key players operating in the Antiviral Drugs market are CogniFit, Elevate, Peak, Rosetta Stone Ltd., LearningRx, Lumosity, HAPPYneuron, Inc., Wise Therapeutics, Inc., Easybrain and Happify, Inc. The competitive landscape is fairly consolidated with top 10 players capturing over 65% of the global antiviral drugs market share. Major players are focusing on portfolio expansion through mergers, acquisitions and licensing agreements.

Explore more related article on this topic: https://www.newswirestats.com/antiviral-drugs-market-propelled-by-rising-demand/

For More Insights On This Topic: https://masstamilan.tv/combine-harvesters-the-machines-that-revolutionized-farming/